Call for Papers: C-BIO 2026 Special Issue

We are delighted to announce our official media partnership with the International Conference on Cell Biology (C-BIO 2026), to be held in Valencia, Spain, from December 2–4, 2026.

As part of this collaboration, JGCMM will publish a dedicated Special Issue featuring selected high-quality research from the conference.

Guest Editors: Prof. Ciro Isidoro & Prof. Danny N. Dhanasekaran

Special Issue Theme: Gene and Cell Metabolism in Medicine

Submission Deadline: December 30, 2026

· 50% Registration Fee Discount for faculty members and researchers from our network (please contact us for the discount code)

· Free APC (Article Processing Charge) for selected high-quality papers submitted to the Special Issue

· Fast-track peer review process

· Free publication of conference abstracts in the Abstract Book

Why Submit to JGCMM Special Issue?

· Dedicated platform for cutting-edge research in gene regulation, cellular metabolism, signaling pathways, and translational medicine

· Enhanced international visibility through our partnership with C-BIO 2026

· Opportunity to publish alongside leading experts in the field

Journal Website: https://jgcmmed.com/jgcmmed

We warmly invite all conference participants and researchers to submit their work. Let’s work together to advance molecular and cellular medicine!

submit

Submit your Manuscript

Latest publications

index

Indexing

EMBASE (Elsevier), Excerpta Medica
DOAJ
Google Scholar
CNKI
CrossRef

issn

eISSN: XXXX-XXXX

currentissueinfo

currentissueinfoauthor

Editor-in-Chief

Ciro Isidoro, PhD.M.D Department of Health Sciences, Università del Piemonte Orientale "Amedeo Avogadro", Novara, Italy

Scope

JGCMM welcomes submissions in, but not limited to, the following areas that have clear translational implications for human health and disease: gene regulation and expression (including mechanisms of transcriptional and post-transcriptional control, alternative splicing, epigenetics, non-coding RNAs, and gene mutations), biochemistry and cellular signaling (such as protein synthesis, processing, post-translational modifications, intracellular trafficking, biochemical signaling pathways, and regulatory networks), cellular metabolism (including metabolic pathways, cell bioenergetics, cell-to-cell communication, metabolic reprogramming in disease, and the integration of nutritional supplements with metabolism, gene expression, and signaling), omics and systems biology (genomics, transcriptomics, proteomics, metabolomics, and integrative multi-omics approaches), pharmacology and therapeutics (targeting gene and protein function, drug discovery, pharmacogenomics, and the development of novel therapeutic strategies including nutraceuticals and epigenetic modulators), autophagy and lysosomal function (the role of autophagy, lysosomal pathways, and protein degradation in cell homeostasis, disease pathogenesis, and therapy), cellular processes (cell death, differentiation, proliferation, motility, secretion, and their dysregulation in pathological conditions), as well as translational and clinical studies that apply molecular and cellular findings to the diagnostics, prognostics, and treatment of human diseases.